Chai Discovery
Backed by
Raised $70M Series A on Aug 6, 2025
Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and, ultimately, drugs.
Explore similar companies to Chai Discovery
Cortical Labs
Lab-grown neurons with silicon chips.
Cradle
Design better proteins.
Manifold Bio
Tissue-targeted medicines, designed in vivo.
Colossal
The de-extinction company.
Loyal
Extending the lifespan of dogs.
Nudge
Whole-brain interfaces for everyday life.
Latent Labs
Making biology programmable.
Science
A brighter tomorrow enabled by neural engineering.
NewLimit
Extending human healthspan.